|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 169.5 USD | +0.97% |
|
+4.29% | +9.39% |
| Apr. 23 | US CDC warns of harmful reactions to fake Botox injections | RE |
| Apr. 22 | Pfizer: new Emblaveo antibiotic approved in the EU | CF |
Health-care companies fell as traders hedged their bets on the outlook for growth in the sector.
AbbVie shares were flat after the drugmaker said it was seeking new products to replace the vacuum left by imminent generic competition for blockbuster Humira.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
02-06-23 1735ET
| 1st Jan change | Capi. | |
|---|---|---|
| +9.39% | 300B | |
| +27.92% | 672B | |
| +27.19% | 570B | |
| -4.59% | 360B | |
| +16.38% | 321B | |
| +7.43% | 217B | |
| +5.90% | 199B | |
| -8.47% | 204B | |
| -8.58% | 149B | |
| -4.99% | 147B |
ABBVIE INC. 
